HONcode Certified

This website is certified by Health On the Net Foundation. Click to verify.

This site complies with the HONcode standard for trustworthy health information: verify here.

Bloggers

Carl Heneghan

Carl Heneghan

Director of the CEBM, GP and clinical lecturer at the University of Oxford.

Ami Banerjee

Ami Banerjee

Cardiology trainee and clinical research fellow at the University of Oxford

Tags

aid
BMJ
BNP
CHD
FDA
flu
GDP
INR
NGO
NHS
RCT

Carl Heneghan in action

CEBM Workshops Video Sample - Carl Heneghan - Diagnostic Tests

See Carl Heneghan in action in the CEBM's workshop videos.
Click here

Twitter TrustTheEvidence.net

tte

    Search the TRIP Database

    TRIP Database


    diet

    Trimming the fat- complicated devices will not solve a simple problem

    Ami Banerjee
    Posted 6th January 2010 @ 03:53pm

    After Christmas and in the run-up to Lent, people are often thinking about New Year’s resolutions and what to give up. One of the most common excesses that people want to address is food. This is the most common time of year to start new diets, exercise regimes and gym memberships, and yet obesity, particularly in childhood, is on the rise. The direct cost of overweight and obesity to the NHS has been estimated at over £3 billion. Inequalities in obesity have been identified between North and South, between men and women, and between social classes, and these inequalities seem to be worse for childhood obesity.

    With the big public health problems of our age, whether smoking and high blood pressure, or diabetes and obesity, there are health inequalities, but there are also cheap, simple, population-wide interventions which can save thousands, if not millions, of lives. In the case of childhood obesity, it is not rocket science- healthier diet, less processed food, more exercise, and there are signs that the childhood obesity epidemic is levelling off. However, there is a constant push by device companies and drug companies to offer more complicated solutions which will produce big profits for them in these disease areas, because they affect so many people in the population.

    This week’s BMJ includes a randomised controlled trial of a novel computerised device, the Mandometer, which provides feedback to participants during meals to slow down speed of eating and reduce total food intake. The trial ran for 12 months comparing the Mandometer with standard lifestyle modification advice and included 106 obese people aged 9 to 17 years. The Mandometer group had a BMI 0.24 units lower than the group receiving standard care. Not only does this seem a paltry difference in BMI; two of the study authors own 60% of the company which produces Mandometer, and so it is unsurprising that they found a positive effect for their device. It is hard to envisage a world where this device is going to be widely used or where it is going to make any difference to childhood obesity. If widely used, such devices will at best only increase the socioeconomic inequalities which already exist in childhood obesity. Surely the simple, population-wide policies of encouraging more exercise and better diet should be promoted instead?

    Syndicate content